By Mill Chart
Last update: Mar 5, 2024
Our stock screening tool has identified GILEAD SCIENCES INC (NASDAQ:GILD) as a strong dividend contender with robust fundamentals. NASDAQ:GILD exhibits commendable financial health and profitability, all while offering a sustainable dividend. Let's delve into each aspect below.
ChartMill provides a Dividend Rating for every stock, ranging from 0 to 10. This rating assesses various dividend aspects, including yield, growth, and sustainability. NASDAQ:GILD earns a 7 out of 10:
ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NASDAQ:GILD, the assigned 5 reflects its health status:
ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:GILD scores a 7 out of 10:
Our Best Dividend screener lists more Best Dividend stocks and is updated daily.
Our latest full fundamental report of GILD contains the most current fundamental analsysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
109.64
-4.9 (-4.28%)
Find more stocks in the Stock Screener
GILEAD SCIENCES INC (NASDAQ:GILD) appears undervalued with strong profitability and reasonable financial health, making it a potential candidate for value investors.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
GILEAD SCIENCES INC (NASDAQ:GILD) shows strong technicals and a high-quality breakout setup, making it a stock to watch for momentum traders.